TNB-486 CD19/CD3: cytokine releasing syndrome (CRS) and neurotoxicity can represent life-threatening complications of CAR-T cells and BiTE therapies, limiting their use especially in frail patients. The gene discussed is CD19; the disease is congenital rubella syndrome.